Hosted on MSN
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
Renovaro Inc. has entered into an exclusive collaboration with Amsterdam University Medical Center to jointly develop blood platelet RNA diagnostics, aiming to enhance disease detection and monitoring ...
This partnership marks an important step forward in the clinical validation and advancement of a promising new approach to disease detection and monitoring. The collaboration will focus on assessing ...
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
Immature platelets, characterised by their high RNA content and larger size, have emerged as valuable biomarkers in modern haematology. The immature platelet fraction (IPF) offers a reliable indicator ...
LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today agreed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results